When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Graves disease

Last reviewed: 21 Oct 2024
Last updated: 22 May 2024

Summary

Definition

History and exam

Key diagnostic factors

  • family history of autoimmune thyroid disease
  • history of tobacco use
  • heat intolerance
  • sweating
  • weight loss
  • palpitations
  • tremor
  • diffuse goiter
  • orbitopathy
Full details

Other diagnostic factors

  • irritability
  • cardiac flow murmur
  • moist, velvety skin
  • scalp hair loss
  • sexual dysfunction
  • muscle weakness
  • thyroid bruit
  • onycholysis
  • vitiligo
  • pretibial myxedema
  • acropachy
  • menstrual irregularity
Full details

Risk factors

  • family history autoimmune thyroid disease
  • female gender
  • tobacco use
  • high iodine intake
  • lithium therapy
  • biologic agent and cytokine therapies
  • radiation
  • radioiodine therapy for benign nodular goiter
  • stress
Full details

Diagnostic tests

1st tests to order

  • TSH
  • TSH receptor antibodies (TRAb)
  • serum free or total T4
  • serum free or total T3
Full details

Tests to consider

  • calculation of total T3/T4 or FT3/FT4 ratio
  • radioactive iodine (I-131 or I-123) or technetium-99 (Tc-99) uptake
  • thyroid isotope scan
  • thyroid peroxidase antibodies (TPOAb)
  • thyroid ultrasound
  • CT or MRI scan of orbit
  • skin biopsy
Full details

Treatment algorithm

ACUTE

thyroid storm

ONGOING

subclinical Graves disease

symptomatic nonpregnant, nonlactating adults

pregnant women

children

Contributors

Authors

Salman Razvi, MD

Consultant Endocrinologist and Senior Lecturer

Translational and Clinical Research Institute, Queen Elizabeth Hospital, Gateshead

Newcastle University

Newcastle upon Tyne

UK

Disclosures

SR has received speaker fees from Merck, IBSA and Abbott Pharmaceuticals Ltd and research funding from Merck.

Acknowledgements

Dr Salman Razvi would like to gratefully acknowledge Dr Petros Perros, Dr Douglas S. Ross, Dr George Hennemann, and Dr Vahab Fatourechi, previous contributors to this topic.

Disclosures

PP, DSR, GH, and VF are authors of references cited in this topic.

Peer reviewers

Elizabeth N. Pearce, MD

Associate Professor of Medicine

Boston University Medical Center

Boston

MA

Disclosures

ENP is a consultant for Scientific Consulting Company GmbH and a management council member for the Iodine Global Network.

Kristien Boelaert, MD, PhD, FRCP

Reader in Endocrinology

Institute of Metabolism and Systems Research

College of Medical and Dental Sciences

University of Birmingham

Birmingham

UK

Disclosures

KB declares that she has no competing interests.

Paul Carroll, MD, FRCP

Clinical Lead for Endocrinology

Chair of Thyroid MDM

Guy’s and St Thomas’ NHS Trust

London

UK

Disclosures

PC declares that he has no competing interests.

David Cooper, MD

Division Head

Endocrinology

Sinai Hospital of Baltimore

Baltimore

MD

Disclosures

DC declares that he has no competing interests.

  • Graves disease images
  • Differentials

    • Toxic nodular goiter
    • Painless and postpartum thyroiditis
    • Gestational hyperthyroidism
    More Differentials
  • Guidelines

    • Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association
    • Management of pediatric Graves' disease
    More Guidelines
  • Patient information

    Graves disease

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer